Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Astellas hit by US patent verdict for incontinence drug
Pharmaphorum
Mon, 06/12/23 - 10:23 am
Tags:
Astellas, Myrbetriq, urinary incontinence, patents, legal
​Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials
BioSpace
Thu, 06/8/23 - 09:54 am
Tags:
Astellas, Kate Therapeutics, gene therapy, X-linked myotubular myopathy
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Tags:
Astellas, Iveric Bio, Bayer, Amgen, M&A
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
Tags:
M&A, antitrust, Amgen, Astellas, Bellus Health, Globus Medical, GSK, Horizon Therapeutics, Merck, NuVasive, Pfizer, Prometheus Biosciences, Seagen
Astellas, Sony Team on Novel ADC Platform for Oncology
BioSpace
Tue, 05/16/23 - 12:20 pm
Tags:
Astellas, Sony Corporation, antibody-drug conjugate, oncology
Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback
Yahoo/Benzinga
Mon, 05/15/23 - 10:07 am
Tags:
Astellas, FDA, hot flashes, Veozah, fezolinetant
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches, AbbVie, Almirall, Apellis Pharmaceuticals, Astellas, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eli Lilly, Genmab, GSK, Iveric Bio, Pfizer, Roche, SAGE Therapeutics, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Vertex Pharmaceuticals
Astellas to acquire eye drug developer Iveric Bio for $5.9B
BioPharma Dive
Mon, 05/1/23 - 11:13 am
Tags:
Astellas, M&A, Iveric Bio, eye health
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Mon, 05/1/23 - 10:13 am
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, clinical trials
FDA again delays Daiichi's plans to challenge Astellas and Novartis for blood cancer market
Fierce Biotech
Fri, 04/21/23 - 10:08 am
Tags:
Daiichi Sankyo, Astellas, Novartis, quizartinib, FDA, blood cancer
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Businesswire
Thu, 04/20/23 - 11:56 am
Tags:
Twist Bioscience, Astellas, VHH antibodies, drug discovery, drug development
FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer
BioSpace
Tue, 04/4/23 - 12:35 pm
Tags:
Merck, Seagen, Astellas, Keytruda, Padcev, metastatic urothelial carcinoma, FDA
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
Tags:
PTC Therapeutics, Novartis, Zolgensma, SMA, Novo Nordisk, Ozempic, obesity, diabetes, Baxter, M&A, Celltrio, Thermo Fisher, Pfizer, Astellas, Xtandi, NIH
Sun, 03/26/23 - 03:36 pm
Tags:
PTC Therapeutics, Novartis, Zolgensma, SMA, Novo Nordisk, Ozempic, obesity, diabetes, Baxter, M&A, Celltrio, Thermo Fisher, Pfizer, Astellas, Xtandi, NIH
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Thu, 03/23/23 - 11:41 am
Tags:
Astellas, zolbetuximab, clinical trials, gastric cancer
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wed, 03/22/23 - 11:19 am
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, drug pricing, NIH, march-in rights
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Fri, 03/17/23 - 10:02 am
Tags:
Pfizer, Astellas, prostate cancer, clinical trials, Enzalutamide, leuprolide
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Thu, 03/9/23 - 09:13 pm
Tags:
Astellas, Xospata, AML, clinical trials
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Thu, 02/23/23 - 10:36 am
Tags:
Astellas, Pompe disease, clinical trials, AT845

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.